| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 02/11/1998 | EP0822984A1 Human tumor necrosis factor receptors |
| 02/11/1998 | EP0822983A1 Apopain |
| 02/11/1998 | EP0822832A1 Cd45rb binding compounds for the prevention of transplant rejection |
| 02/11/1998 | EP0822823A1 Anionic oxygen radicals containing therapeutic agents and their use in pain relief |
| 02/11/1998 | EP0822822A1 Controlled release of miotic and mydriatic drugs in the anterior chamber |
| 02/11/1998 | EP0822818A2 Selective modulators of peroxisome proliferator activated receptor-gamma, and methods for the use thereof |
| 02/11/1998 | EP0822813A1 A combination of a 5-ht uptake inhibitor with a selective 5-ht 1a? antagonist |
| 02/11/1998 | EP0822812A1 Topical treatment and/or prevention of sagging subcutaneous muscle and overlying cutaneous tissue using acetylcholine precursors and catecholamines |
| 02/11/1998 | EP0714407B1 Composition and methods using nitroxides to avoid oxygen toxicity |
| 02/11/1998 | EP0630263B1 Pharmaceutical composition having site-specific delivery |
| 02/11/1998 | CN1173184A Identitication, purification and uses of leczymes and carbohydrate ligands |
| 02/11/1998 | CN1172646A Fill material for soft gelatin pharmaceutical dosage form containing antiflatulent |
| 02/10/1998 | US5717097 HIV protease inhibitors useful for the treatment of AIDS |
| 02/10/1998 | US5717092 Compounds with improved multi-drug resistance activity |
| 02/10/1998 | US5717074 Macrophage-derived inflammatory mediator (MIP-2) |
| 02/10/1998 | US5716992 Topical applying to human skin |
| 02/10/1998 | US5716991 Pharmaceutical compositions comprising paracetamol and L-cysteine or a precursor thereof |
| 02/10/1998 | US5716981 A stent coated with paclitaxel, a taxan derivative and a polymeric carrier; medical equipment for deblocking |
| 02/10/1998 | US5716978 Methods of treating circadian rhythm disorders |
| 02/10/1998 | US5716976 Administering anorexients |
| 02/10/1998 | US5716962 Treating hyperglycemia and hyperinsulinemia |
| 02/10/1998 | US5716957 Administering a hypoglycemic agent or dopaminergic agent once a day and within two hours after waking in morning |
| 02/10/1998 | US5716952 Topical application |
| 02/10/1998 | US5716933 Adjustment the prolactin and glucoccorticosteroid ratio in blood |
| 02/10/1998 | US5716932 Process for the long term reduction of body fat stores, insulin resistance, and hyperinsulinemia in vertebrates |
| 02/10/1998 | US5716931 Administering lantibiotic by aerosol |
| 02/10/1998 | US5716929 Inhibitors of interleukin-1β converting enzyme |
| 02/10/1998 | US5716648 Compositions for use in the regulation of subnormal pH values in the intestinal tract and for treatment of bowel diseases |
| 02/10/1998 | US5716595 Intraperative, intravascular and endoscopic tumor and lesion detection and therapy with monovalent antibody fragments |
| 02/10/1998 | US5715835 Methods for treating and reducing the potential for cardiovascular disease using methioninase compositions |
| 02/10/1998 | CA2079205C Use of hyaluronic acid and forms to prevent arterial restenosis |
| 02/10/1998 | CA2053258C Use of non-absorbable synthetic sulfated polysaccharides to decrease cholesterol absorption |
| 02/05/1998 | WO1998004913A1 Molecular model for vla-4 inhibitors |
| 02/05/1998 | WO1998004709A2 Herpes simplex virus icp4 is an inhibitor of apoptosis |
| 02/05/1998 | WO1998004686A2 Pro-protein converting enzyme |
| 02/05/1998 | WO1998004682A1 Adipogenic differentiation of human mesenchymal stem cells |
| 02/05/1998 | WO1998004585A2 Novel human macrophage antigen |
| 02/05/1998 | WO1998004312A1 Novel methods for embolizing vascular sites with an embolizing composition comprising dimethylsulfoxide |
| 02/05/1998 | WO1998004290A2 Compositions comprising an inducing agent and an anti-viral agent for the treatment of blood, viral and cellular disorders |
| 02/05/1998 | WO1998004289A2 Pharmaceutical composition containing a 5ht2c antagonist and a d2 antagonist |
| 02/05/1998 | WO1998004287A1 The use of proteinase inhibitors for prevention or reduction of bone resorption |
| 02/05/1998 | WO1998004280A2 Topical composition containing amino acid in combination with either interferon or thymidine derivatives for treating viral or inflammation diseases |
| 02/05/1998 | WO1998004279A1 Pharmaceutical compositions for the treatment of transplant rejection, autoimmune or inflammatory conditions comprising cyclosporin a and 40-0-(2-hydroxiethyl)-rapamycin |
| 02/05/1998 | WO1998004273A1 Method for treating gastrointestinal damage |
| 02/05/1998 | WO1998004260A1 Substituted biphenyl sulfonamide endothelin antagonists |
| 02/05/1998 | WO1998004259A1 ANTITHROMBOTIC AND ANTIATHEROGENIC PHARMACEUTICAL COMPOSITION INCLUDING A THIENOPYRIDINE DERIVATIVE AND AN HMG-CoA-REDUCTASE INHIBITOR |
| 02/05/1998 | WO1998004256A1 Amino acid compositions and use thereof in immunosuppression |
| 02/05/1998 | WO1998004253A1 Composition of pyruvate and anti-cortisol compounds and method for increasing protein concentration in a mammal |
| 02/05/1998 | WO1998004247A1 Cell adhesion inhibitors |
| 02/05/1998 | DE19631084A1 Verwendung von (Meth)acrylsäure-Copolymeren zur Erhöhung der Permeabilität der Schleimhaut Use of (meth) acrylic acid copolymers to increase the permeability of the mucosal |
| 02/05/1998 | DE19631037A1 Formulation of bactericide and terpene-containing plant extract |
| 02/05/1998 | CA2262013A1 Herpes simplex virus icp4 is an inhibitor of apoptosis |
| 02/05/1998 | CA2261974A1 Molecular model for vla-4 inhibitors |
| 02/05/1998 | CA2261813A1 Pharmaceutical composition containing a 5ht2c antagonist and a d2 antagonist |
| 02/05/1998 | CA2261781A1 Composition of pyruvate and anti-cortisol compounds and method for increasing protein concentration in a mammal |
| 02/05/1998 | CA2261575A1 Novel human macrophage antigen |
| 02/05/1998 | CA2261567A1 The use of proteinase inhibitors for prevention or reduction of bone resorption |
| 02/05/1998 | CA2260956A1 Amino acid compositions and use thereof in immunosuppression |
| 02/05/1998 | CA2260047A1 Novel methods for embolizing vascular sites with an embolizing composition comprising dimethylsulfoxide |
| 02/05/1998 | CA2232710A1 Medically beneficial preparation for topical use containing amino acids |
| 02/04/1998 | EP0821964A2 Use of adenosine and adenosine derivatives for analgesia and attenuation of stress or stress responses |
| 02/04/1998 | EP0821953A2 Anticoccidial methods and feedstuffs |
| 02/04/1998 | EP0821952A1 Use of isoxazole and crotonic acid amide derivatives for the modulation of apoptosis |
| 02/04/1998 | EP0821793A1 Methods of screening for therapeutic agents using novel apoptosis-modulating proteins |
| 02/04/1998 | EP0821728A1 Tie-2 ligands, methods of making and uses thereof |
| 02/04/1998 | EP0821592A1 Compositions and methods for regulating hair growth |
| 02/04/1998 | EP0821589A1 Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs |
| 02/04/1998 | EP0821586A1 A pharmaceutical composition containing benzimidazole for inhibiting the growth of cancers |
| 02/03/1998 | US5714503 Compounds and methods for inhibition of HIV and related viruses |
| 02/03/1998 | US5714468 Injecting neurotoxins into localized pain sites |
| 02/03/1998 | US5714381 DNA encoding human alpha 1 adrenergic receptors and uses thereof |
| 02/03/1998 | US5714167 Reversibly forming supramolecular complex of active agent with perturbant; drug delivery |
| 02/03/1998 | US5714166 Bioactive and/or targeted dendrimer conjugates |
| 02/03/1998 | US5714148 Chemical compounds |
| 02/03/1998 | CA2081564C Synergistic therapeutic compositions and methods |
| 01/29/1998 | WO1998003873A1 Treatment and diagnosis of cancer |
| 01/29/1998 | WO1998003634A1 Methods for identifying vasoprotective agents |
| 01/29/1998 | WO1998003632A1 Bivalent agonists for g-protein coupled receptors |
| 01/29/1998 | WO1998003572A1 Antiviral linear polymers |
| 01/29/1998 | WO1998003551A1 Cd6 ligand |
| 01/29/1998 | WO1998003539A1 G-protein coupled receptor hnfds78 |
| 01/29/1998 | WO1998003201A1 Novel medicinal compositions for therapeutic use |
| 01/29/1998 | WO1998003196A1 Intradermal bovine polynucleotide vaccine |
| 01/29/1998 | WO1998003183A1 Use of 5,6-dihydro-5-azacytidine in the treatment of prostate cancer |
| 01/29/1998 | WO1998003180A2 Use of sex steroids function modulators to treat wounds and fibrotic disorders |
| 01/29/1998 | WO1998003179A1 Analgesic composition for treatment of migraine headaches |
| 01/29/1998 | WO1998003174A1 Method for treating tumors having high ldl requirements employing mtp inhibitors |
| 01/29/1998 | WO1998003157A1 Granulates of hexahydropyrazine derivatives which can be administered orally |
| 01/29/1998 | WO1998003084A1 Nutritious food preparations and methods for making them |
| 01/29/1998 | WO1998003069A1 Method for lowering serum lipid levels employing an mtp inhibitor in combination with another cholesterol lowering drug |
| 01/29/1998 | WO1998003059A1 Galanin |
| 01/29/1998 | WO1997047732A3 Hexameric fusion proteins and uses therefor |
| 01/29/1998 | WO1997036609A3 Combinations of vasopressin and adrenergic agents for the treatment of cardiac arrest |
| 01/29/1998 | CA2632790A1 Use of sex steroid function modulators to treat wounds and fibrotic disorders |
| 01/29/1998 | CA2262863A1 Antiviral linear polymers |
| 01/29/1998 | CA2262008A1 Bivalent agonists for g-protein coupled receptors |
| 01/29/1998 | CA2261162A1 Method for treating tumors having high ldl requirements employing mtp inhibitors |
| 01/29/1998 | CA2260995A1 Method for lowering serum lipid levels employing an mtp inhibitor in combination with another cholesterol lowering drug |
| 01/29/1998 | CA2232142A1 Cd6 ligand |
| 01/28/1998 | EP0821068A2 Novel sphingolipids and a process thereto |